share_log

Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares

Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares

海王星宣佈納斯達克聽證會小組決定將普通股退市
Accesswire ·  03/06 21:30

LAVAL, QC / ACCESSWIRE / March 6, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), today announced an update on the status of its appeal against the determination of the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") to delist the Company's common shares ("Common Shares").

QC LAVAL /ACCESSWIRE/2024年3月6日/海王星健康解決方案公司(“海王星” 或 “公司”)(納斯達克股票代碼:NEPT)今天宣佈了其對納斯達克股票市場有限責任公司(“納斯達克”)上市資格工作人員決定將公司普通股(“普通股”)退市的上訴的最新情況。

As previously disclosed, the Company had been notified by Nasdaq on November 30, 2023 that it was not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market (NASDAQ Listing Rule 5550(a)(2)), as the bid price for the Common Shares on Nasdaq closed below US$1.00 for 30 consecutive trading days and that it was not in compliance with the minimum stockholders' equity requirement (NASDAQ Listing Rule 5550(b)(1)), as the Company's stockholders' equity was below the minimum US$2.5 million required for continued listing. The Company submitted a request for a hearing to the to the Nasdaq Hearings Panel (the "Panel") to appeal the delisting determination.

正如先前披露的那樣,納斯達克已於2023年11月30日通知該公司,該公司未遵守繼續在納斯達克資本市場上市的最低出價要求(納斯達克上市規則5550(a)(2)),因爲納斯達克普通股的出價連續30個交易日收於1.00美元以下,並且不符合最低股東權益要求(納斯達克上市規則 5550 (b) (1)),因爲該公司的股東權益低於繼續上市所需的最低250萬美元。該公司向納斯達克聽證小組(“小組”)提交了聽證請求,以對除名決定提出上訴。

The Panel hearing took place on February 29, 2024. On March 5, the Company received a written decision of the Panel pursuant to which the Panel upheld the delisting determination and denied the Company's requests for additional time to rectify the deficiencies. The Company has the right to request a review of the Panel Decision from the Nasdaq Listing Council within 15 days from the date of the Panel Decision.

小組聽證會於2024年2月29日舉行。3月5日,公司收到了該小組的書面決定,根據該決定,該小組維持了除名決定,並駁回了該公司延長時間以糾正缺陷的請求。公司有權在小組決定之日起15天內要求納斯達克上市委員會對小組決定進行審查。

The trading of the Company's Common Shares on Nasdaq will be suspended as of the opening of business on March 7, 2024. The Company is seeking to have its Common Shares quoted on the OTCQB Venture Market of the OTCMarkets.

自2024年3月7日開業之日起,公司在納斯達克的普通股交易將暫停。該公司正在尋求將其普通股在OTCQB上市 場外交易市場的風險市場。

About Neptune Wellness Solutions Inc.
Neptune is a consumer-packaged goods company that aims to innovate health and wellness products. Founded in 1998 and headquartered in Laval, Quebec with a United States headquarters in Jupiter, Florida, the company focuses on developing a portfolio of high-quality, affordable consumer products that align with the latest market trends for natural, sustainable, plant-based and purpose-driven lifestyle brands. The company's products are available in more than 29,000 retail locations and include well-known organic food and beverage brands such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. With its efficient and adaptable manufacturing and supply chain infrastructure, the company can quickly respond to consumer demand, and introduce new products through retail partners and e-commerce channels. Please visit neptunewellness.com for more details.

關於 Neptune 健康解決方案公司
海王星是一家消費品包裝公司,旨在創新健康和保健產品。該公司成立於1998年,總部位於魁北克省拉瓦爾,美國總部位於佛羅里達州朱庇特,專注於開發符合天然、可持續、植物和以目的爲導向的生活方式品牌的最新市場趨勢的高質量、實惠的消費產品組合。該公司的產品在超過29,000個零售點有售,其中包括知名的有機食品和飲料品牌,例如Sprout Organics、Nosh和Nurturme,以及Biodroga和Forest Remedies等營養品品牌。憑藉其高效且適應性強的製造和供應鏈基礎設施,該公司可以快速響應消費者需求,並通過零售合作伙伴和電子商務渠道推出新產品。請訪問 neptunewellness.com 了解更多詳情。

Disclaimer - Safe Harbor Forward-Looking Statements
Statements in this news release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", "projects", "anticipates", "will", "should" or "plans" to be uncertain and forward-looking. Forward-looking statements relate to future events or future performance and reflect management's expectations or beliefs regarding future events including, but not limited to, statements with respect to the listing and timing of listing of the Company's common shares on the OTCQB Venture Market of the OTCMarkets. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking statements and information included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement and the "Cautionary Note Regarding Forward-Looking Information" section contained in Neptune's latest Annual Report on Form 10-K and its subsequent filings, which are available on EDGAR at www.sec.gov/edgar.shtml. All forward-looking statements in this news release are made as of the date of this news release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

免責聲明-安全港前瞻性陳述
本新聞稿中非歷史或當前事實陳述的陳述構成適用證券法所指的 “前瞻性陳述”。此類前瞻性陳述涉及已知和未知的風險、不確定性和其他未知因素,這些因素可能導致海王星的實際業績與歷史業績或此類前瞻性陳述所表達或暗示的任何未來業績存在重大差異。除了明確描述此類風險和不確定性的陳述外,我們敦促讀者將標有 “相信”、“信念”、“期望”、“打算”、“項目”、“預期”、“將來”、“應該” 或 “計劃” 等術語的陳述視爲不確定和具有前瞻性的陳述。前瞻性陳述與未來事件或未來業績有關,反映了管理層對未來事件的預期或信念,包括但不限於有關公司普通股在場外交易市場的OTCQB風險投資市場上市和上市時間的陳述。儘管公司認爲在本新聞稿中準備前瞻性信息或前瞻性陳述時使用的假設和因素是合理的,但不應過分依賴此類信息,也無法保證此類事件將在披露的時間範圍內或根本無法保證此類事件會發生。本新聞稿中包含的前瞻性陳述和信息自本新聞稿發佈之日起作出,除非適用的證券法要求,否則公司沒有義務公開更新此類前瞻性信息或前瞻性信息以反映新信息、後續事件或其他情況。提醒讀者不要過分依賴這些前瞻性陳述,這些陳述僅代表截至本新聞發佈之日。本警示聲明和海王星最新的10-K表年度報告及其後續文件中包含的 “關於前瞻性信息的警示說明” 部分對本新聞稿中包含的前瞻性陳述進行了明確的全面限定,這些報告可在EDGAR上查閱,網址爲www.sec.gov/edgar.shtml。本新聞稿中的所有前瞻性陳述均自本新聞發佈之日起作出。除非法律要求,否則海王星不承諾更新任何此類前瞻性陳述,無論是由於新信息、未來事件還是其他原因。

Going Concern
As of the date this press release, there is minimal cash balance at the Company. The Company requires funding in the very near term in order to continue its operations and is considering all strategic alternatives that may be available, including debt financing and asset divestitures, in order to generate cash to fund operations. The Company's lack of cash resources and current share price may adversely affect its ability to raise new capital, maintain its NASDAQ listing and execute its business strategy. If the Company is unable to obtain funding in the near term, it may have to cease operations and liquidate its assets. These conditions cast substantial doubt about the Company's ability to continue as a going concern.

繼續關注
截至本新聞稿之日,該公司的現金餘額微乎其微。該公司需要在短期內提供資金才能繼續運營,並正在考慮所有可能的戰略選擇,包括債務融資和資產剝離,以產生現金爲運營提供資金。該公司缺乏現金資源和當前股價可能會對其籌集新資金、維持在納斯達克上市和執行業務戰略的能力產生不利影響。如果公司無法在短期內獲得資金,則可能不得不停止運營並清算其資產。這些條件使人們對公司繼續作爲持續經營企業的能力產生了嚴重懷疑。

Media Contacts:
media@neptunecorp.com

媒體聯繫人:
media@neptunecorp.com

SOURCE: Neptune Wellness Solutions, Inc.

來源:海王星健康解決方案有限公司


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論